# Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)

> **NCT03148015** · — · COMPLETED · sponsor: **Sentara Norfolk General Hospital** · enrollment: 30 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **OTHER:** Biomarkers

## Key facts

- **NCT ID:** NCT03148015
- **Lead sponsor:** Sentara Norfolk General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-10-01
- **Primary completion:** 2020-12-31
- **Final completion:** 2020-12-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2022-05-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03148015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03148015, "Novel Molecular Targets for Ductal Carcinoma In Situ (DCIS)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03148015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*